TRANSFORMING LIVES BY DESIGN

Serial Number 78408873
606

Registration Progress

Application Filed
Apr 27, 2004
Under Examination
Apr 26, 2005
Approved for Publication
Jan 12, 2005
Published for Opposition
Feb 1, 2005
Registered

Trademark Image

TRANSFORMING LIVES BY DESIGN

Basic Information

Serial Number
78408873
Filing Date
April 27, 2004
Published for Opposition
February 1, 2005
Abandonment Date
October 27, 2005
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Oct 27, 2005
Classes
005 042

Rights Holder

Protein Design Labs, Inc.

03
Address
34801 Campus Drive
Fremont, CA 94555

Ownership History

Protein Design Labs, Inc.

Original Applicant
03
Fremont, CA

Protein Design Labs, Inc.

Owner at Publication
03
Fremont, CA

Legal Representation

Attorney
Cynthia R. Adwere

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

10 events
Date Code Type Description Documents
Dec 27, 2005 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Dec 27, 2005 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Apr 26, 2005 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 1, 2005 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 12, 2005 NPUB O NOTICE OF PUBLICATION Loading...
Dec 1, 2004 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Nov 26, 2004 ALIE A ASSIGNED TO LIE Loading...
Nov 23, 2004 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 22, 2004 DOCK D ASSIGNED TO EXAMINER Loading...
May 5, 2004 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, antibodies used to prevent, treat and diagnose diseases, namely, auto-immune conditions, inflammatory conditions, allergic conditions, and cancer
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
Pharmaceutical drug development services; development of antibodies to treat autoimmune and inflammatory diseases and conditions, asthma, and cancer
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005 042